05/01/2025
3:21 PM | Relmada Therapeutics (Subject)
Squadron Capital Management LLC (Filed by)
| Form SCHEDULE 13G | |
04/28/2025
12:46 PM | Relmada Therapeutics (Filer)
| Form 424B5 | |
04/28/2025
12:18 PM | Relmada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/27/2025
3:40 PM | Relmada Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/27/2025
3:42 PM | Relmada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/06/2025
5:38 AM | Relmada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/27/2025
6:30 AM | Relmada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/06/2025
4:29 PM | Relmada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
6:49 AM | Relmada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2024
6:30 AM | Relmada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
8:41 AM | Deep Track Capital, LP (Filed by)
Relmada Therapeutics (Subject)
| Form SC 13G/A | |
Get the Latest News and Ratings for RLMD and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Relmada Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
10/23/2024
3:27 PM | CASAMENTO CHARLES J (Reporting)
Relmada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
11:15 PM | Relmada Therapeutics (Filer)
| Form EFFECT | |
09/11/2024
4:46 PM | Kelly Paul Edward (Reporting)
Relmada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
4:46 PM | Relmada Therapeutics (Issuer)
Shenouda Maged (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
4:47 PM | CASAMENTO CHARLES J (Reporting)
Relmada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
4:47 PM | Relmada Therapeutics (Issuer)
TRAVERSA SERGIO (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2024
3:23 PM | Relmada Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/29/2024
8:23 PM | CASAMENTO CHARLES J (Reporting)
Relmada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
8:23 PM | Ence Chuck (Reporting)
Relmada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
8:24 PM | Fedeli Fabiana (Reporting)
Relmada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
8:24 PM | GLASSPOOL JOHN (Reporting)
Relmada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
8:24 PM | Kelly Paul Edward (Reporting)
Relmada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
8:24 PM | Relmada Therapeutics (Issuer)
Shenouda Maged (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
8:25 PM | Relmada Therapeutics (Issuer)
TRAVERSA SERGIO (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Buy RLMD Stock Free RLMD Stock Alerts